Lowry Simon C
SEC insider (Form 3/4/5 filer). CIK 0002044279. SVP, R&D, CMO at Emergent BioSolutions Inc. (EBS). 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 29, 2026. Located in GAITHERSBURG, MD.
Companies Lowry Simon C has filed insider reports for
- Emergent BioSolutions Inc. (EBS): Officer, SVP, R&D, CMO
Lowry Simon C
CIK: 0002044279
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Emergent BioSolutions Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Apr 29, 2026EBS
Emergent BioSolutions Inc.
AwardDirect100.1K shares- - Mar 5, 2026EBS
Emergent BioSolutions Inc.
Tax PaymentDirect10.6K shares at avg. $8.44$90K - Mar 3, 2026EBS
Emergent BioSolutions Inc.
AwardDirectEmployee Stock Option (Right to buy)
44.8K shares- - Dec 14, 2025EBS
Emergent BioSolutions Inc.
Tax PaymentDirect3.5K shares at avg. $11.41$40K - Mar 6, 2025EBS
Emergent BioSolutions Inc.
AwardDirect62.5K shares- - Dec 15, 2024EBS
Emergent BioSolutions Inc.
AwardDirect29.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 29, 2026 | EBS Emergent BioSolutions Inc. | Award | 100,111 | - | $0 | Direct |
| Mar 5, 2026 | EBS Emergent BioSolutions Inc. | Tax Payment | 10,636 | $8.44 | $89,768 | Direct |
| Mar 3, 2026 | EBS Emergent BioSolutions Inc. | Award Employee Stock Option (Right to buy) | 44,834 | - | - | Direct |
| Dec 14, 2025 | EBS Emergent BioSolutions Inc. | Tax Payment | 3,543 | $11.41 | $40,426 | Direct |
| Mar 6, 2025 | EBS Emergent BioSolutions Inc. | Award | 62,500 | - | - | Direct |
| Dec 15, 2024 | EBS Emergent BioSolutions Inc. | Award | 29,482 | - | $0 | Direct |
1-6 of 6 transactions